TILLY'S, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TILLY'S, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 2, 2019 | $170.61M | Mar 29, 2019 |
| FY2018 | Nov 3, 2018 | $146.83M | Mar 29, 2019 |
| FY2018 | Aug 4, 2018 | $157.41M | Mar 29, 2019 |
| FY2018 | May 5, 2018 | $123.63M | Mar 29, 2019 |
| FY2018 | Feb 3, 2018 | $164.32M | Mar 29, 2019 |
| FY2018 | Oct 28, 2017 | $152.82M | Mar 29, 2019 |
| FY2018 | Jul 29, 2017 | $138.81M | Mar 29, 2019 |
| FY2018 | Apr 29, 2017 | $120.95M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $160.22M | Mar 30, 2018 |
| FY2017 | Oct 29, 2016 | $152.11M | Mar 30, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $164.47M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $149.70M | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | $165.66M | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | $202.75M | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $276.66M | Apr 11, 2024 |
| FY2020 | Jan 30, 2021 | $58.26M | Apr 1, 2021 |
| FY2020 | Oct 31, 2020 | $40.66M | Apr 1, 2021 |
| FY2020 | Aug 1, 2020 | $41.67M | Apr 1, 2021 |
| FY2020 | May 2, 2020 | $1.59M | Apr 1, 2021 |
| FY2020 | Feb 1, 2020 | $52.13M | Apr 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | ($17.45M) | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | ($46.23M) | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | ($34.49M) | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | $9.68M | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $64.25M | Apr 11, 2024 |
| FY2020 | Jan 30, 2021 | $8.87M | Apr 1, 2021 |
| FY2020 | Oct 31, 2020 | $2.11M | Apr 1, 2021 |
| FY2020 | Aug 1, 2020 | $5.27M | Apr 1, 2021 |
| FY2020 | May 2, 2020 | ($17.40M) | Apr 1, 2021 |
| FY2020 | Feb 1, 2020 | $6.27M | Apr 1, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | ($19.34M) | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | ($49.85M) | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | ($30.98M) | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | $11.19M | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $87.60M | Apr 11, 2024 |
| FY2020 | Jan 30, 2021 | $14.11M | Apr 1, 2021 |
| FY2020 | Oct 31, 2020 | $3.54M | Apr 1, 2021 |
| FY2020 | Aug 1, 2020 | $7.71M | Apr 1, 2021 |
| FY2020 | May 2, 2020 | ($28.40M) | Apr 1, 2021 |
| FY2020 | Feb 1, 2020 | $8.50M | Apr 1, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $183.81M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $199.55M | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | $196.64M | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | $191.56M | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $189.07M | Apr 11, 2024 |
| FY2022 | Jan 30, 2021 | $145.23M | Apr 13, 2023 |
| FY2021 | Feb 1, 2020 | $158.25M | Apr 14, 2022 |
| FY2020 | Feb 2, 2019 | $149.42M | Apr 1, 2021 |
| FY2019 | Feb 3, 2018 | $151.38M | Apr 1, 2020 |
| FY2018 | Jan 28, 2017 | $149.13M | Mar 29, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.10M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | ($42.02M) | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | ($6.73M) | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | ($1.42M) | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $63.40M | Apr 11, 2024 |
| FY2022 | Jan 30, 2021 | $38.90M | Apr 13, 2023 |
| FY2021 | Feb 1, 2020 | $36.43M | Apr 14, 2022 |
| FY2020 | Feb 2, 2019 | $46.74M | Apr 1, 2021 |
| FY2019 | Feb 3, 2018 | $32.71M | Apr 1, 2020 |
| FY2013 | Feb 1, 2014 | $43.79M | Apr 1, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.69M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $8.22M | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | $13.96M | Apr 9, 2026 |
| FY2024 | Jan 28, 2023 | $15.12M | Apr 10, 2025 |
| FY2023 | Jan 29, 2022 | $13.43M | Apr 11, 2024 |
| FY2022 | Jan 30, 2021 | $8.47M | Apr 13, 2023 |
| FY2021 | Feb 1, 2020 | $14.30M | Apr 14, 2022 |
| FY2020 | Feb 2, 2019 | $14.92M | Apr 1, 2021 |
| FY2019 | Feb 3, 2018 | $13.75M | Apr 1, 2020 |
| FY2018 | Jan 28, 2017 | $17.05M | Mar 29, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $310.76M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $342.46M | Apr 9, 2026 |
| FY2024 | Feb 3, 2024 | $429.55M | Apr 10, 2025 |
| FY2023 | Jan 28, 2023 | $475.75M | Apr 11, 2024 |
| FY2022 | Jan 29, 2022 | $504.82M | Apr 13, 2023 |
| FY2021 | Jan 30, 2021 | $507.46M | Apr 14, 2022 |
| FY2020 | Feb 1, 2020 | $546.64M | Apr 1, 2021 |
| FY2019 | Feb 2, 2019 | $293.17M | Apr 1, 2020 |
| FY2018 | Feb 3, 2018 | $290.11M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $290.51M | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $225.62M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $241.59M | Apr 9, 2026 |
| FY2024 | Feb 3, 2024 | $284.68M | Apr 10, 2025 |
| FY2023 | Jan 28, 2023 | $298.95M | Apr 11, 2024 |
| FY2022 | Jan 29, 2022 | $330.11M | Apr 13, 2023 |
| FY2021 | Jan 30, 2021 | $346.83M | Apr 14, 2022 |
| FY2020 | Feb 1, 2020 | $386.74M | Apr 1, 2021 |
| FY2019 | Feb 2, 2019 | $129.84M | Apr 1, 2020 |
| FY2018 | Feb 3, 2018 | $129.69M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $101.29M | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $85.14M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $100.87M | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | $144.87M | Apr 9, 2026 |
| FY2025 | Jan 28, 2023 | $176.80M | Apr 9, 2026 |
| FY2024 | Jan 29, 2022 | $174.71M | Apr 10, 2025 |
| FY2023 | Jan 30, 2021 | $160.62M | Apr 11, 2024 |
| FY2022 | Feb 1, 2020 | $159.90M | Apr 13, 2023 |
| FY2021 | Feb 2, 2019 | $163.33M | Apr 14, 2022 |
| FY2020 | Feb 3, 2018 | $160.43M | Apr 1, 2021 |
| FY2019 | Jan 28, 2017 | $189.22M | Apr 1, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | ($91.64M) | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | ($74.19M) | Apr 9, 2026 |
| FY2024 | Feb 3, 2024 | ($27.96M) | Apr 10, 2025 |
| FY2023 | Jan 28, 2023 | $6.53M | Apr 11, 2024 |
| FY2022 | Jan 29, 2022 | $7.75M | Apr 13, 2023 |
| FY2021 | Jan 30, 2021 | $5.14M | Apr 14, 2022 |
| FY2020 | Feb 1, 2020 | $6.28M | Apr 1, 2021 |
| FY2019 | Feb 2, 2019 | $13.34M | Apr 1, 2020 |
| FY2018 | Feb 3, 2018 | $16.40M | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $51.02M | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $46.31M | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | $21.06M | Apr 9, 2026 |
| FY2024 | Feb 3, 2024 | $47.03M | Apr 10, 2025 |
| FY2023 | Jan 28, 2023 | $73.53M | Apr 11, 2024 |
| FY2022 | Jan 29, 2022 | $42.20M | Apr 13, 2023 |
| FY2021 | Jan 30, 2021 | $76.18M | Apr 14, 2022 |
| FY2020 | Feb 1, 2020 | $70.14M | Apr 1, 2021 |
| FY2020 | Feb 2, 2019 | $68.16M | Apr 1, 2021 |
| FY2020 | Feb 3, 2018 | $53.20M | Apr 1, 2021 |
| FY2019 | Jan 28, 2017 | $78.99M | Apr 1, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 30, 2021 | 0 | Apr 1, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Apr 1, 2021 |
| FY2020 | May 2, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Feb 1, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Nov 2, 2019 | 0 | Apr 1, 2021 |
| FY2020 | Aug 3, 2019 | 0 | Apr 1, 2021 |
| FY2020 | May 4, 2019 | 0 | Apr 1, 2021 |
| FY2019 | Feb 2, 2019 | 0 | Apr 1, 2020 |
| FY2019 | Nov 3, 2018 | 0 | Apr 1, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 0 | Apr 9, 2026 |
| FY2025 | Feb 1, 2025 | (1) | Apr 9, 2026 |
| FY2025 | Feb 3, 2024 | (1) | Apr 9, 2026 |
| FY2020 | Jan 30, 2021 | 0 | Apr 1, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Apr 1, 2021 |
| FY2020 | May 2, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Feb 1, 2020 | 0 | Apr 1, 2021 |
| FY2020 | Nov 2, 2019 | 0 | Apr 1, 2021 |
| FY2020 | Aug 3, 2019 | 0 | Apr 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Feb 2, 2013 | 0 | Apr 3, 2013 |
| FY2012 | Jan 28, 2012 | 20.00M | Apr 3, 2013 |